Physician
Stainbrook, Tuesdae
Stainbrook, Tuesdae was paid $229K by Medicaid between Dec 2020 and Dec 2024, across 33 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 19% of everything it billed.
33Billing provider infoSTAINBROOK, TUESDAE
DU BOIS, PA 15801
DU BOIS, PA 15801
33aNPI1588670285assigned 08/01/2006
33bProvider typeInfectious Disease Physician
28Total paid$229K
24GClaims11,907
24DCodes billed33
24AFirst – last monthDec 2020 – Dec 2024
Compared with peers
Next to other Infectious Disease Physician providers in Pennsylvania
Rank by total paid#14 of 87
Median peer was paid$26K
This provider vs. median9.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 28 | $697.02 | |
| 2021 | 224 | $7K | |
| 2022 | 755 | $15K | |
| 2023 | 4,589 | $75K | |
| 2024incomplete | 6,311 | $131K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 19% | 1,601 | 1,452 | $44K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 750 | 701 | $29K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 12% | 723 | 653 | $29K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 12% | 745 | 733 | $27K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 9.3% | 572 | 564 | $21K |
| 80053 | Comprehensive metabolic panel | 6.5% | 1,439 | 1,339 | $15K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 1,709 | 1,608 | $9K |
| G0433 | Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening | 3.7% | 535 | 533 | $9K |
| 99243 | 3.0% | 99 | 97 | $7K | |
| 84443 | Thyroid stimulating hormone (TSH) | 2.9% | 379 | 360 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 536 | 418 | $7K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 184 | 130 | $5K |
21 more codes
| 80061 | Lipid panel | 1.7% | 372 | $4K |
| 86704 | 1.1% | 155 | $2K | |
| 87340 | 1.1% | 161 | $2K | |
| 86706 | <1% | 157 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 264 | $2K |
| 86803 | <1% | 134 | $2K | |
| 86592 | <1% | 415 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 66 | $797.20 |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $786.24 |
| 80076 | <1% | 83 | $630.89 | |
| 81025 | <1% | 148 | $603.26 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 17 | $518.76 |
| 85652 | <1% | 192 | $504.90 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 161 | $493.00 |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 53 | $468.60 |
| 85027 | <1% | 33 | $181.94 | |
| G0008 | Administration of influenza virus vaccine | <1% | 28 | $176.00 |
| 81001 | <1% | 40 | $89.40 | |
| 84439 | <1% | 16 | $88.00 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 100 | $9.90 |
| 82105 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.